DISCONTINUATION OF ANTICOAGULANT THERAPY AFTER A FIRST EVENT: SP
€10.00
Tax included
This study the methodology "solid" makes a decision strategy based on elements simple clinical and biological safely stop a anticoagulant therapy in women who had a first spontaneous venous thrombotic episode and treated for 5 to 7 months.
Security policy
(edit with the Customer Reassurance module)
Delivery policy
(edit with the Customer Reassurance module)
This study the methodology "solid" makes a decision strategy based on elements simple clinical and biological safely stop a anticoagulant therapy in women who had a first spontaneous venous thrombotic episode and treated for 5 to 7 months.
SKU-1087
2050-01-01
New
16 other products in the same category:
This study the methodology "solid" makes a decision strategy based on elements simple clinical and biological safely stop a anticoagulant therapy in women who had a first spontaneous venous thrombotic episode and treated for 5 to 7 months.